Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C |
Low-temperature fluorescence emission changes in thylakoids induced by acetyl glyceryl ether phosphorylcholine (AGEPC). |
1987 |
Arch. Biochem. Biophys. |
pmid:3813566
|
Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C |
Enhancement of chlorophyll a fluorescence yield, low-temperature F685/F730 fluorescence emission ratio, and electron transport rate by ether phospholipids (platelet activating factor and analogs) in isolated chloroplasts. |
1989 |
Arch. Biochem. Biophys. |
pmid:2817899
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Toyoshima K et al. |
Coenzyme A-independent transacylation in amnion-derived (WISH) cells. |
1994 |
Arch. Biochem. Biophys. |
pmid:7944398
|
Sugiura T et al. |
Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor. |
1994 |
Arch. Biochem. Biophys. |
pmid:8203898
|
RodrÃguez Roisin R |
[Platelet activating factor and bronchial asthma. Is it relevant?]. |
1997 |
Arch. Bronconeumol. |
pmid:9280556
|
Travers J et al. |
Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783. |
1998 |
Arch. Dermatol. Res. |
pmid:9836508
|
Modschiedler K et al. |
Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. |
2000 |
Arch. Dermatol. Res. |
pmid:10664013
|
Kemény L et al. |
Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. |
1996 |
Arch. Dermatol. Res. |
pmid:8844132
|
Lazanas M et al. |
PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. |
1988 |
Arch. Dermatol. Res. |
pmid:3395143
|
Kemény L et al. |
Pharmacological studies on dithranol-induced irritative dermatitis in mice. |
1989 |
Arch. Dermatol. Res. |
pmid:2529819
|
Judge MR et al. |
Platelet activating factor (PAF) and lyso-PAF in psoriasis. |
1994 |
Arch. Dermatol. Res. |
pmid:7818279
|
Jørgensen KM et al. |
Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. |
2010 |
Arch. Dermatol. Res. |
pmid:20041255
|
Alappatt C et al. |
Acute keratinocyte damage stimulates platelet-activating factor production. |
2000 |
Arch. Dermatol. Res. |
pmid:10867814
|
de Boissieu D et al. |
[Study of platelet-activating factor (PAF) in stools of newborn infants with hemorrhagic colitis]. |
1991 Aug-Sep |
Arch. Fr. Pediatr. |
pmid:1929756
|
Morville P and Heymann M |
[Regulation of perinatal pulmonary circulation]. |
1989 Jun-Jul |
Arch. Fr. Pediatr. |
pmid:2783008
|
Dubovsky SL et al. |
Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. |
1989 |
Arch. Gen. Psychiatry |
pmid:2735813
|
Carlioglu A et al. |
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome. |
2014 |
Arch. Gynecol. Obstet. |
pmid:24840107
|
Hruby ZW et al. |
Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model. |
1991 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:1668710
|
Wysocki H |
The role of polymorphonuclear neutrophils in myocardial damage during ischemia and reperfusion. |
1992 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:1485826
|
Rosenbaum JT et al. |
Synthesis of platelet activating factor by ocular tissue from inflamed eyes. |
1991 |
Arch. Ophthalmol. |
pmid:2003804
|
Rubin RM et al. |
Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. |
1988 |
Arch. Ophthalmol. |
pmid:3261165
|
Noguchi K et al. |
The detection of platelet-activating factor in inflamed human gingival tissue. |
1989 |
Arch. Oral Biol. |
pmid:2783040
|
Hirafuji M and Shinoda H |
Increased prostaglandin I2 and thromboxane A2 production by rat dental pulp after intravenous administration of endotoxin. |
1994 |
Arch. Oral Biol. |
pmid:7695514
|
Krause S et al. |
Aggregation behaviour of blood granulocytes in patients with periodontal disease. |
1990 |
Arch. Oral Biol. |
pmid:2390026
|
Nohutcu RM et al. |
Effects of hormones and cytokines on stimulation of adenylate cyclase and intracellular calcium concentration in human and canine periodontal-ligament fibroblasts. |
1993 |
Arch. Oral Biol. |
pmid:7506523
|
Mann EA et al. |
Phospholipid metabolite expression by head and neck squamous cell carcinoma. |
1994 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:8018329
|
Rehse K et al. |
New 1H-pyrazole-4-carboxamides with antiplatelet activity. |
2009 |
Arch. Pharm. (Weinheim) |
pmid:19051198
|
Disselnkötter H et al. |
[Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)]. |
1985 |
Arch. Pharm. (Weinheim) |
pmid:4051690
|
Xu LF et al. |
Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. |
2011 |
Arch. Pharm. Res. |
pmid:21380808
|
Huh H et al. |
PAF antagonistic activity of 2-hydroxy-3-methoxybenzoic acid glucose ester from Gentiana scabra. |
1998 |
Arch. Pharm. Res. |
pmid:9875472
|
Grypioti AD et al. |
Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. |
2005 |
Arch. Toxicol. |
pmid:15995853
|
Massicot F et al. |
Inhibitory effects of a platelet activating factor-antagonist 48740RP in cyclosporin-induced nephrotoxicity in the rat as assessed by renal glutathione metabolism parameters. |
1991 |
Arch. Toxicol. Suppl. |
pmid:1687197
|
Misawa M and Sugiyama Y |
An airway hyperresponsiveness model in rat allergic asthma. |
1993 |
Arerugi |
pmid:8507151
|
Tsukioka K et al. |
[Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma]. |
1993 |
Arerugi |
pmid:8507159
|
Kakazu T et al. |
[Effect of platelet-activating factor (PAF) on eosinophil adhesion to plasma-coated glass using eosinophilic cell lines (EoL-1, EoL-3)]. |
1994 |
Arerugi |
pmid:8031255
|
Kawata E et al. |
Effect of benzodiazepine on antigen-induced eosinophil infiltration into guinea pig conjunctiva. |
1996 |
Arerugi |
pmid:8752723
|
Arima M et al. |
[Platelet activating factor (PAF)-induced late asthmatic response in sensitized but not in non-sensitized guinea pigs]. |
1992 |
Arerugi |
pmid:1520069
|
Hashimoto T et al. |
[Effect of tazanolast on platelet activating factor-induced airway hyperresponsiveness in guinea pigs]. |
1992 |
Arerugi |
pmid:1280089
|
Ganbo T et al. |
[The inhibitory effects of platelet activating factor (PAF) on ciliary activity of human paranasal sinus mucosa]. |
1992 |
Arerugi |
pmid:1482297
|
Tomooka M et al. |
[Azelastine inhibits bronchoconstriction induced by histamine and leukotriene C4]. |
1988 |
Arerugi |
pmid:2906534
|
Makino S |
[Platelet activating factor in allergic reaction]. |
1988 |
Arerugi |
pmid:3052368
|
Nakahodo K et al. |
Histamine release from rabbit platelets by platelet-activating factor (PAF). |
1994 |
Arerugi |
pmid:7515227
|
Akagi M et al. |
Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats. |
1995 |
Arerugi |
pmid:7646374
|
Arima M et al. |
[Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma]. |
1991 |
Arerugi |
pmid:2069513
|
Kobayashi Y et al. |
[Inhibitory effect of suplatast tosilate on eosinophil migration]. |
2000 |
Arerugi |
pmid:10944827
|
Imai T et al. |
[The role of thromboxane A2 in the development of airway responsiveness after platelet activating factor inhalation in dogs]. |
1991 |
Arerugi |
pmid:2029218
|
Fukuda T et al. |
[Antigen-induced biphasic eosinophil infiltration in the airways of actively sensitized guinea pigs and its inhibition by PAF antagonist and cyclosporin A]. |
1990 |
Arerugi |
pmid:2222197
|
Nakamura T et al. |
[Platelet-activating factor in Japanese cedar pollinosis]. |
1990 |
Arerugi |
pmid:2222198
|
Imai T et al. |
[Relation of platelet activating factor induced airway hyperresponsiveness to thromboxane A2 and neutrophil in dogs]. |
1993 |
Arerugi |
pmid:8250720
|
Imai T et al. |
[The role of 5-lipoxygenase products in the development of airway responsiveness induced by platelet activating factor inhalation in dogs]. |
1991 |
Arerugi |
pmid:1854258
|
Arima M et al. |
[Effect of BAY u3405-thromboxane A2 receptor antagonist, on biphasic airway responses induced by platelet-activating factor in actively sensitized guinea pigs]. |
1995 |
Arerugi |
pmid:7575136
|
Ichikawa Y et al. |
[Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells]. |
1989 |
Arerugi |
pmid:2783037
|
de Almeida PJ and Pires JG |
[Antiplatelet agents: specific agonist inhibitors]. |
1989 |
Arq. Bras. Cardiol. |
pmid:2575895
|
de Almeida PJ et al. |
[Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. |
1987 |
Arq. Bras. Cardiol. |
pmid:3328601
|
Dentan C et al. |
PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation. |
1994 |
Arterioscler. Thromb. |
pmid:8123638
|
Mori TA et al. |
Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9081682
|
D'Andrea D et al. |
Induction of tissue factor in the arterial wall during recurrent thrombus formation. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12869352
|
Tselepis AD et al. |
PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. |
1995 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:7583554
|
Tsoukatos DC et al. |
Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9437199
|
Montrucchio G et al. |
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. |
2000 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:10634803
|
Tsimikas S et al. |
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17626905
|
Stengel D et al. |
Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9157961
|
Frostegård J et al. |
Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9157962
|
Kimura M et al. |
Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9301630
|
De Geest B et al. |
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. |
2000 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11031226
|
Li N et al. |
Platelet-leukocyte cross talk in whole blood. |
2000 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11116075
|
Calabresi L et al. |
Endothelial protection by high-density lipoproteins: from bench to bedside. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12969988
|
Nilsson J et al. |
Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor. |
1998 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9445250
|
Ilveskero S et al. |
Procoagulant activity on platelets adhered to collagen or plasma clot. |
2001 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11304482
|
Whatley RE et al. |
Endothelium from diverse vascular sources synthesizes platelet-activating factor. |
1988 May-Jun |
Arteriosclerosis |
pmid:3130833
|
Rouis M et al. |
Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate. |
1990 Mar-Apr |
Arteriosclerosis |
pmid:2317158
|
Kirchmaier CM et al. |
A platelet stimulating fraction in human and animal tissues. |
1980 |
Artery |
pmid:6971084
|
Sperling RI et al. |
Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. |
1990 |
Arthritis Rheum. |
pmid:2167685
|
Sperling RI et al. |
Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. |
1987 |
Arthritis Rheum. |
pmid:3663263
|
Chatham WW et al. |
Ligand-dependent release of active neutrophil collagenase. |
1990 |
Arthritis Rheum. |
pmid:2154997
|
Tselepis AD et al. |
Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity. |
1999 |
Arthritis Rheum. |
pmid:10025933
|
Kowanko IC et al. |
Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants. |
1992 |
Arthritis Rheum. |
pmid:1322671
|
Simoni J et al. |
Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. |
1994 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:7994374
|
Edwards CM et al. |
Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood. |
1997 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:9285052
|
Wratten ML et al. |
Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins. |
2000 |
Artif Organs |
pmid:11012537
|
Imanishi N et al. |
Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. |
1994 |
Arzneimittelforschung |
pmid:8192697
|
Lohde C et al. |
Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro. |
1992 |
Arzneimittelforschung |
pmid:1375025
|
Nagaoka J et al. |
Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models. |
1991 |
Arzneimittelforschung |
pmid:1663352
|
Asaka N et al. |
Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. |
2010 |
Arzneimittelforschung |
pmid:21117500
|
Brecht HM et al. |
Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. |
1991 |
Arzneimittelforschung |
pmid:1646613
|
Berti F et al. |
New pharmacological data on the bronchospasmolytic activity of bamifylline. |
1988 |
Arzneimittelforschung |
pmid:3365275
|
Tsunoda H et al. |
Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation. |
1991 |
Arzneimittelforschung |
pmid:1867658
|
Natsume Y et al. |
Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats. |
1994 |
Arzneimittelforschung |
pmid:7848333
|
Houlihan WJ et al. |
Antitumor activity of a piperidine phospholipid. |
1994 |
Arzneimittelforschung |
pmid:7848363
|
Giudice A et al. |
Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine. |
1996 |
Arzneimittelforschung |
pmid:8740089
|
Tsunoda H et al. |
Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. |
1990 |
Arzneimittelforschung |
pmid:2085331
|
Cheung HT et al. |
Inhibition of platelet aggregation by diterpene acids from Pinus massoniana resin. |
1994 |
Arzneimittelforschung |
pmid:8135873
|
Tasaka K et al. |
Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine. |
1990 |
Arzneimittelforschung |
pmid:1705425
|
Tasaka K et al. |
Effects of antiallergic agents including levocabastine on experimental rhinitis in rats. |
1994 |
Arzneimittelforschung |
pmid:7514877
|
Tasaka K et al. |
Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats. |
1994 |
Arzneimittelforschung |
pmid:7910745
|
Tanaka T et al. |
Effect of a novel xanthine derivative on experimental ulcers in rats. |
1993 |
Arzneimittelforschung |
pmid:8329000
|
Evangelista S et al. |
Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine. |
1995 |
Arzneimittelforschung |
pmid:7612055
|
Akagi M et al. |
Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. |
1997 |
Arzneimittelforschung |
pmid:9450165
|
Kapui Z et al. |
Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs. |
1999 |
Arzneimittelforschung |
pmid:10483515
|